Lista de obras - Craig R. Lee - Dominio Público Uruguay

Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism

artículo científico publicado en 2011

Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome

artículo científico publicado en 2018

Blood pressure-associated polymorphism controls ARHGAP42 expression via serum response factor DNA binding

scientific article published on 23 January 2017

CYP2C19 Genotype-Guided Antiplatelet Therapy and 30-Day Outcomes After Percutaneous Coronary Intervention

scientific article published on 01 February 2019

CYP2C19-guided antiplatelet therapy: a cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary intervention

scientific article published on 26 July 2017

CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype.

artículo científico publicado en 2014

Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis

artículo científico publicado en 2016

Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery Disease.

artículo científico publicado en 2017

Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence

artículo científico publicado en 2020

Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention

scientific article published on 01 April 2019

Clinical outcomes of CYP2C19 genotype-guided antiplatelet therapy: existing evidence and future directions

article

Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data

scientific article published on 11 February 2020

Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study

artículo científico publicado en 2008

Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K/Akt signaling pathways.

artículo científico publicado en 2007

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

artículo científico publicado en 2002

Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients

artículo científico publicado en 2013

Cytochrome P450-derived epoxyeicosatrienoic acids and coronary artery disease in humans: a targeted metabolomics study

artículo científico publicado en 2016

Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism.

artículo científico publicado en 2011

Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice

artículo científico publicado en 2011

Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart

artículo científico publicado en 2011

Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice.

artículo científico publicado en 2010

Epoxyeicosanoids promote organ and tissue regeneration.

artículo científico publicado en 2013

Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice

artículo científico publicado en 2011

Epoxyeicosatrienoic acids and cardioprotection: the road to translation

artículo científico publicado en 2014

Evaluation of cytochrome P4502C9 metabolic activity with tolbutamide in CYP2C91 heterozygotes.

artículo científico publicado en 2002

Frequency and clinical outcomes of CYP2C19 genotype-guided escalation and de-escalation of antiplatelet therapy in a real-world clinical setting

scientific article published on 18 July 2019

Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity

artículo científico publicado en 2014

Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study

artículo científico publicado en 2006

Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans

artículo científico publicado en 2011

Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk.

artículo científico publicado en 2007

High-impact articles related to the pharmacotherapeutic management of systolic heart failure.

artículo científico publicado en 2004

Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1).

artículo científico publicado en 2007

Implementation of inpatient models of pharmacogenetics programs.

artículo científico publicado en 2016

Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy.

artículo científico publicado en 2017

Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance

artículo científico publicado en 2017

Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humans.

artículo científico publicado en 2012

Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact.

artículo científico publicado en 2017

Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients

artículo científico publicado en 2018

Projected impact of pharmacogenomic testing on medications beyond antiplatelet therapy in percutaneous coronary intervention patients

scientific article published on 28 April 2020

Relation Between Digital Peripheral Arterial Tonometry and Brachial Artery Ultrasound Measures of Vascular Function in Patients With Coronary Artery Disease and in Healthy Volunteers ⬇️

artículo científico publicado el 6 de diciembre de 2011

Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction

artículo científico publicado en 2007

Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis

artículo científico publicado en 2005

Research Highlights: Highlights from the latest articles in personalized cardiovascular medicine

artículo científico publicado en 2012

Resolvin Infectious Inflammation by Targeting the Host Response

artículo científico publicado en 2015

Role of endothelial soluble epoxide hydrolase in cerebrovascular function and ischemic injury.

artículo científico publicado en 2013

Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function

artículo científico publicado en 2006

Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer

artículo científico publicado en 2015

Sex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium

artículo científico publicado en 2016

Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis

artículo científico publicado en 2015

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.

artículo científico publicado en 2017

The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease.

artículo científico publicado en 2014

The impact of ezetimibe on endothelial function and other markers of cardiovascular risk.

artículo científico publicado en 2009

Twenty-four hour tolbutamide plasma concentration as a phenotypic measure of CYP2C9 activity.

artículo científico publicado en 2005

Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease.

artículo científico publicado en 2017

Vascular characterization of mice with endothelial expression of cytochrome P450 4F2.

artículo científico publicado en 2014

Vasopressin: a new target for the treatment of heart failure

artículo científico publicado en 2003

Warfarin dosing and the promise of pharmacogenomics.

artículo científico publicado en 2007

Warfarin initiation and the potential role of genomic-guided dosing.

artículo científico publicado en 2005

beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.

artículo científico publicado en 2005

Lista de obras de Craig R. Lee

Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism

Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome

Blood pressure-associated polymorphism controls ARHGAP42 expression via serum response factor DNA binding

CYP2C19 Genotype-Guided Antiplatelet Therapy and 30-Day Outcomes After Percutaneous Coronary Intervention

CYP2C19-guided antiplatelet therapy: a cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary intervention

CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype.

Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis

Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery Disease.

Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence

Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention

Clinical outcomes of CYP2C19 genotype-guided antiplatelet therapy: existing evidence and future directions

Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data

Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study

Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K/Akt signaling pathways.

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients

Cytochrome P450-derived epoxyeicosatrienoic acids and coronary artery disease in humans: a targeted metabolomics study

Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism.

Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice

Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart

Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice.

Epoxyeicosanoids promote organ and tissue regeneration.

Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice

Epoxyeicosatrienoic acids and cardioprotection: the road to translation

Evaluation of cytochrome P4502C9 metabolic activity with tolbutamide in CYP2C91 heterozygotes.

Frequency and clinical outcomes of CYP2C19 genotype-guided escalation and de-escalation of antiplatelet therapy in a real-world clinical setting

Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity

Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study

Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans

Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk.

High-impact articles related to the pharmacotherapeutic management of systolic heart failure.

Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1).

Implementation of inpatient models of pharmacogenetics programs.

Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy.

Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance

Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humans.

Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact.

Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients

Projected impact of pharmacogenomic testing on medications beyond antiplatelet therapy in percutaneous coronary intervention patients

Relation Between Digital Peripheral Arterial Tonometry and Brachial Artery Ultrasound Measures of Vascular Function in Patients With Coronary Artery Disease and in Healthy Volunteers ⬇️

Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction

Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis

Research Highlights: Highlights from the latest articles in personalized cardiovascular medicine

Resolvin Infectious Inflammation by Targeting the Host Response

Role of endothelial soluble epoxide hydrolase in cerebrovascular function and ischemic injury.

Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function

Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer

Sex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium

Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.

The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease.

The impact of ezetimibe on endothelial function and other markers of cardiovascular risk.

Twenty-four hour tolbutamide plasma concentration as a phenotypic measure of CYP2C9 activity.

Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease.

Vascular characterization of mice with endothelial expression of cytochrome P450 4F2.

Vasopressin: a new target for the treatment of heart failure

Warfarin dosing and the promise of pharmacogenomics.

Warfarin initiation and the potential role of genomic-guided dosing.

beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.